Castleark Management LLC acquired a new position in shares of Cooper Companies Inc (NYSE:COO) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,890 shares of the medical device company’s stock, valued at approximately $453,000.
Other hedge funds have also bought and sold shares of the company. YorkBridge Wealth Partners LLC increased its holdings in Cooper Companies by 2.1% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after purchasing an additional 11 shares during the last quarter. Archford Capital Strategies LLC grew its position in shares of Cooper Companies by 116.7% in the 1st quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock worth $135,000 after acquiring an additional 363 shares in the last quarter. Acrospire Investment Management LLC grew its position in shares of Cooper Companies by 50.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after acquiring an additional 200 shares in the last quarter. Visionary Asset Management Inc. acquired a new position in shares of Cooper Companies in the 2nd quarter worth approximately $201,000. Finally, Penserra Capital Management LLC grew its position in shares of Cooper Companies by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock worth $211,000 after acquiring an additional 102 shares in the last quarter. Institutional investors own 96.04% of the company’s stock.
In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Castleark Management LLC Takes Position in Cooper Companies Inc (NYSE:COO)” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/27/castleark-management-llc-takes-453000-position-in-cooper-companies-inc-the-coo.html.
Cooper Companies Inc (NYSE COO) traded up 0.243% during mid-day trading on Friday, hitting $240.995. The stock had a trading volume of 50,367 shares. The firm has a market cap of $11.80 billion, a P/E ratio of 34.561 and a beta of 0.54. Cooper Companies Inc has a 1-year low of $158.73 and a 1-year high of $256.39. The stock has a 50 day moving average of $239.84 and a 200-day moving average of $232.96.
Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.58 by $0.06. The firm had revenue of $556.00 million for the quarter, compared to analyst estimates of $552.32 million. Cooper Companies had a net margin of 18.63% and a return on equity of 13.78%. Cooper Companies’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.30 EPS. Analysts predict that Cooper Companies Inc will post $9.73 EPS for the current fiscal year.
Several research analysts have recently commented on the company. Jefferies Group LLC set a $250.00 target price on Cooper Companies and gave the stock a “buy” rating in a research report on Thursday, August 17th. KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, October 20th. Cleveland Research reiterated a “buy” rating on shares of Cooper Companies in a research report on Tuesday, August 22nd. Robert W. Baird set a $273.00 target price on Cooper Companies and gave the stock a “buy” rating in a research report on Monday, October 16th. Finally, Zacks Investment Research lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $261.11.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.